Ultragenyx Pharmaceutical Inc. · NASDAQ:RARE

BlackRock, Inc. reported a 5.10% stake in Ultragenyx Pharmaceutical Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed Apr 24, 2025

BlackRock, Inc. reported a 5.10% stake in Ultragenyx Pharmaceutical Inc., 4,820,931 shares, as a passive investor on Mar 31, 2025. Filed Apr 24, 2025 (Schedule 13G/A).

Stake
5.10%
Shares
4,820,931
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.5.10%4,820,931

Source

View original at SEC

Related